The current diagnostic algorithm for coronary artery disease is variable between regions of the world and has limitations. In this touchCARDIO interview, we speak with Dr Morten Bøttcher (Aarhus University, Aarhus, Denmark) to discuss details of the current diagnostic algorithm for coronary artery disease and its limitations.
The abstract entitled ‘DanNICAD-2 – Perfusion scanning with MR or PET after a positive CT coronary angiography’ was presented at the European Society of Cardiology (ESC) Congress 2022, 26 – 29 August 2022.
Questions:
- Could you give us a brief overview of the current diagnostic algorithm for coronary artery disease? (0:16)
- What are the limitations of this algorithm? (1:36)
Disclosures: Morten Bøttcher is on the advisory board for Acarix, AstraZeneca , Bayer, Novartis, Novo Nordisk and Sanofi.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ESC 2022
Access more content on Cardiovascular Disease here
